Skip to content
WorldMedicine.uaWorldMedicine.ua
  • About company
  • Products
  • Pharmacovigilance
  • Articles
  • Contacts
  • Eng
    • Укр
    • Рус
Prognosismodifying therapy in patients with CAD: how to optimize treatment?

Authors: Khanyukov A.A., Professor, Doctor of Medical Sciences, Head of the Department of Internal Medicine,

Aspects of the use of metabolic therapy in patients with cognitive impairment in post-COVID syndrome

Authors: V. O. Kholin, K. M. Poletaeva, A. A. Tikhonenko, N. Yu. D. F. Chebotareva

Ripronate is a new drug meldonium from a European manufacturer

The pathogenesis of each disease is based on one or another typical pathological process: hypoxia,

Improving the effectiveness of treatment for patients with diabetic retinopathy

Authors: Skrypnyk R.1, Skrypnychenko I.1, Dziuba N.2 1 Bogomolets National Medical University, Kyiv, Ukraine 2

By category
  • Uncategorized
  • For doctors
  • For patients
Products Articles
artoxan (4) artrocol (5) breveluck (3) carbarutin (2) carmetadin (3) cataxol (1) choludexan (24) clodifen (3) clodifen-drops (4) cocarnit (15) doprokin (1) doramycin (4) fersinol (2) fersinol-z (5) fluzamed (3) fosfomed (3) galara (1) inoseda (1) lekoxa (1) levoximed (7) medexol (1) medotilin (14) medrolgin (2) medrolgin-drops (1) medulac (7) metacartin (8) muskomed (11) nevralon (2) opefera (19) orcipol (7) polijen (5) protecta (6) reytoil (3) ripronat (4) rolinoz (1) ronocit (4) sertofen (8) stressofit (5) terbinorm (9) ulsepan (13) ziromin (4) аллева (2) лекокса (1) родинир (2) ротацеф (1)
Аренда яхты
  • Homepage
  • Privacy policy
  • Pharmacovigilance
  • Contacts
Всі права захищені 2023 © World Medicine
  • About company
  • Products
  • Pharmacovigilance
  • Articles
  • Contacts
    • Укр
    • Rus
    • Eng

Login

Lost your password?